Inositol treatment of obsessive-compulsive disorder
Fux M, Levine J, Aviv A, Belmaker RH
Published in American Journal of Psychiatry, Vol. 153 (9), pp. 1219-21
Methodology
Double-blind crossover trial of inositol 18 g daily versus placebo in patients with obsessive-compulsive disorder.
Key Findings
Inositol significantly reduced obsessive-compulsive symptom scores compared with placebo during the active phase.
Conclusions
Inositol may reduce obsessive thoughts, but replication has been inconsistent.
Limitations
Very small crossover sample; older trial with dated methodology.
Supplements Studied
Inositol significantly reduced obsessive-compulsive symptom scores compared with placebo during the active phase.
Outcomes Measured
Inositol significantly reduced obsessive-compulsive symptom scores compared with placebo during the active phase
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.